Gadoxetate Disodium Injection

Gadoxetate Disodium Injection
Product Description

Gadoxetate Disodium Injection is a liver-specific MRI contrast agent for enhanced imaging: dynamic phase shows perfusion, hepatobiliary phase highlights lesion–liver contrast. It improves detection and characterization of small HCC and metastases, offers better lesion contrast, no ionizing radiation, and aids staging and procedure planning; contraindicated or cautioned in severe renal impairment/dialysis or prior gadolinium allergy.

Read more Show less

Chengdu Brilliant Pharmaceutical Group.Inc

  • Country/Region:
    China
  • On CPHI since:
    2026
View company profile
Categories
more categories Show less

Chengdu Brilliant Pharmaceutical Group.Inc

  • Country/Region:
    China
  • On CPHI since:
    2026
View company profile

More Products from Chengdu Brilliant Pharmaceutical Group.Inc (4)

  • Azithromycin for Injection

    Product Azithromycin for Injection

    Azithromycin for Injection is a macrolide antibiotic used for susceptible bacterial infections of the respiratory tract, skin and soft tissue, and urogenital tract. It is given intravenously when oral therapy is not feasible or for more severe cases, often followed by oral step-down. It offers high tissue ...
  • Budesonide Inhalation Suspension

    Product Budesonide Inhalation Suspension

    Budesonide Inhalation Suspension provides potent local anti-inflammatory action in the airways, reduces airway hyperresponsiveness, and is delivered directly to the lungs via nebulization for fast onset with relatively low systemic exposure—helping improve asthma symptom control and reduce the risk of acut...
  • Pembrolizumab biosimilar

    Product Pembrolizumab biosimilar

    Pembrolizumab biosimilar is an anti–PD-1 monoclonal antibody that blocks PD-1/PD-L1 inhibition and activates T cells against tumors. It is used for multiple advanced cancers, such as non–small cell lung cancer, melanoma, head and neck squamous cell carcinoma, lymphoma, and MSI-H/dMMR tumor-agnostic indicat...
  • Semaglutide

    Product Semaglutide

    Semaglutide is a GLP-1 receptor agonist that stimulates insulin secretion in a glucose-dependent manner, suppresses glucagon, delays gastric emptying, and reduces appetite. It is mainly used for glycemic control in type 2 diabetes; some doses are approved for weight management in obesity/overweight, with e...